-
Posted by
Two Blokes Jun 23 -
Filed in
Stock
-
7 views
Walgreens faces a buyout by Sycamore Partners after years of declining profitability, heavy debt, and failed strategic pivots in a rapidly changing retail pharmacy landscape. Shareholders are offered $11.45 per share plus a potential $3 per share from future VillageMD asset sales, but the latter payout is uncertain and risky. The deal is not finalized; Q3 earnings and the upcoming shareholder vote are key, but the company's long-term prospects as a public entity appear bleak.
